In AML, the gene encoding the bromodomain-containing protein 4 (BRD4) was identified by an epigenetically focused systematic in vivo RNAi screen at the Cold Spring Harbor Laboratory as highly essential for promoting proliferation and blocking differentiation. The gene discussed is BRD4; the disease is acute myeloid leukemia.